Related Experiment Videos
Anticoagulation and the heart
1Anticoagulation Services, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Insights
Cardiovascular disease increases thrombosis risk, leading to heart attack and stroke. Anticoagulant therapy is crucial for preventing and treating these thrombotic disorders in the cardiovascular system.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pharmacology
Background:
- Cardiovascular diseases elevate thrombosis risk, potentially causing myocardial infarction, cardiac death, and stroke.
- Valvular heart disease and prosthetic materials disrupt blood flow, promoting platelet aggregation and coagulation.
- Understanding thrombosis pathophysiology is key to preventing cardiovascular events.
Purpose of the Study:
- To review the role of anticoagulant therapy in managing cardiovascular thrombotic disorders.
- To highlight the importance of clinical trials in establishing effective antithrombotic strategies.
Main Methods:
- Literature review focusing on thrombosis mechanisms in cardiovascular disease.
- Analysis of the role of anticoagulant therapy in clinical settings.
- Discussion of principles guiding antithrombotic treatment development.
Main Results:
- Anticoagulant therapy is a cornerstone in preventing and treating cardiovascular thrombosis.
- Physiologic and pathobiologic factors influence thrombosis development and management.
- Clinical trials are essential for validating new antithrombotic treatments.
Conclusions:
- Anticoagulant therapy plays a vital role in managing thrombotic risks associated with cardiovascular disease.
- Further research through clinical trials is needed to optimize antithrombotic treatments for broad application.
Abstract:
Cardiovascular disease is associated with a heightened risk of thrombosis that can manifest as acute myocardial infarction, cardiac death, and stroke. Similarly, valvular heart disease (which alters blood-flow dynamics) and the insertion of prosthetic materials (which stimulates localized thrombosis on foreign surfaces) are associated with platelet aggregation and thrombin-mediated bioamplification of the coagulation cascade. Physiologic principles and pathobiologic mechanisms determine the preferred means either to prevent or attenuate both thrombosis and subsequent cardiovascular events. Anticoagulant therapy in hospital- and outpatient-based settings has appropriately assumed a central role in the prevention and treatment of thrombotic disorders of the cardiovascular system. Carefully-designed clinical trials will establish safe and effective antithrombotic therapies for wide-scale implementation.